Medicine and Dentistry
In Vitro
100%
Endothelial Cell
100%
Cell Survival
100%
Cell Function
100%
Tyrosine-Kinase Inhibitor
100%
Dasatinib
57%
Ponatinib
42%
Cell Adhesion Molecule
35%
Nilotinib
35%
Therapeutic Procedure
28%
Cell Migration
28%
Cells
21%
Programmed Cell Death
21%
Assay
21%
Intercellular Adhesion Molecule 1
21%
Atherosclerosis
21%
Vascular Cell Adhesion Molecule 1
21%
Endothelial Leukocyte Adhesion Molecule 1
21%
Lactate Dehydrogenase
14%
Drug Megadose
14%
Necrosis
14%
Atherogenesis
14%
Leukocyte Recruitment
14%
Bosutinib
14%
Imatinib
14%
Chronic Myelogenous Leukemia
14%
Cell Viability
7%
Endothelium
7%
Aptitude
7%
Antibody
7%
Interpersonal Communication
7%
Wound Healing
7%
Cell Proliferation
7%
Inpatient
7%
Serum
7%
Myocardial Infarction
7%
Cell Metabolism
7%
Lipoprotein
7%
Enzyme Linked Immunosorbent Assay
7%
Lipid Storage
7%
Conflict
7%
Wound Closure
7%
Umbilical Vein
7%
Arteriosclerosis Obliterans
7%
Side Effect
7%
Artery Thrombosis
7%
Brain Ischemia
7%
Cell Line
7%
Photography
7%
Tumor Necrosis Factor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Survival
100%
Protein Tyrosine Kinase Inhibitor
100%
Dasatinib
61%
Ponatinib
46%
Nilotinib
38%
Cell Adhesion Molecule
38%
Atherosclerosis
23%
Intercellular Adhesion Molecule 1
23%
E-Selectin
23%
Vascular Cell Adhesion Molecule 1
23%
Lactate Dehydrogenase
15%
Necrosis
15%
Apoptosis
15%
Imatinib
15%
Chronic Myeloid Leukemia
15%
Bosutinib
15%
Atherogenesis
15%
Lipid
7%
Heart Infarction
7%
Antibody
7%
Cell Proliferation
7%
Cell Death
7%
Wound Healing
7%
Side Effect
7%
Brain Ischemia
7%
Lipoprotein
7%
Artery Thrombosis
7%
Peripheral Occlusive Artery Disease
7%
Wound
7%
Enzyme-Linked Immunosorbent Assay
7%
Cell Viability
7%